Featured News

On May 11, Sophia Schilling, Legislative Assistant to Congresswoman Betty McCollum (MN-04), distributed a letter to the Members of the Congressional Celiac Disease Caucus. This is a notable event as it was the first official letter to the Caucus members.

Celiac Disease Foundation Chief Executive, Marilyn G. Geller, was recently interviewed by The Waiting Room, a patient information website, to highlight the work and accomplishments of the Foundation.

The Celiac Disease Foundation is pleased to announce the establishment of two international celiac disease research prizes to inspire a new generation of researchers whose work in celiac disease will be invaluable.

A recent study identified several biochemical abnormalities associated with testing positive for celiac disease in an antibody test. These biochemical abnormalities could be a predictor of celiac disease and become a tool to reduce delayed diagnosis.

The Celiac Disease Foundation is in discussion with a team at the University of Colorado, Denver to develop the first-ever, FDA-approved pediatric PRO (patient-reported outcome tool).

A recent study found that avoidant/restrictive food intake disorder (ARFID) is common among people with celiac disease.

Last week, Celiac Disease Foundation Patient Advocates met with the staff of their Members of Congress to advocate for expanded NIH funding for celiac disease research in FY2023, and including celiac disease in the Congressionally Directed Medical Research Programs.  

Comments submitted to U.S. Preventive Services Task Force on Draft Research Plan: Preventive Services for Food Insecurity.

On April 8 and April 9, the Celiac Disease Foundation is sponsoring the Columbia University Celiac Disease Center International Symposium on Celiac Disease.

The Celiac Disease Foundation is sponsoring the Columbia University Celiac Disease Center Livestream International Symposium. Join us on Friday April 8 - Saturday April 9.